- Patent Title: Combination of oncolytic virus with immune checkpoint modulators
-
Application No.: US15325576Application Date: 2015-07-16
-
Publication No.: US10765710B2Publication Date: 2020-09-08
- Inventor: Laurence Zitvogel , Xavier Preville , Laetitia Fend
- Applicant: Institut Gustave-Roussy , Transgene SA
- Applicant Address: FR Villejuif FR Illkirch Graffenstaden
- Assignee: Institut Gustave-Roussy,Transgene SA
- Current Assignee: Institut Gustave-Roussy,Transgene SA
- Current Assignee Address: FR Villejuif FR Illkirch Graffenstaden
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@646987b5
- International Application: PCT/EP2015/066353 WO 20150716
- International Announcement: WO2016/009017 WO 20160121
- Main IPC: A61K35/768
- IPC: A61K35/768 ; A61K35/28 ; C07K16/20 ; C07K16/30 ; C12N5/00 ; A61K9/00 ; A61K38/19 ; A61K39/395 ; C07K16/28 ; C12N7/00 ; A61K39/00
Abstract:
The present invention provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulator(s) for use for the treatment of a proliferative disease such as cancer. It also relates to a kit comprising an oncolytic virus and one or more immune checkpoint modulator(s) in separate containers. It also concerns a pharmaceutical composition comprising effective amount of an oncolytic virus and one or more immune checkpoint modulator(s).
Public/Granted literature
- US20170143780A1 COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS Public/Granted day:2017-05-25
Information query
IPC分类:
